A 10-patient case study on the influence of two different probiotics on individual intestinal microbiota

Journal of Alternative and Complementary Medicine

Volumn 20, Issue 10, 2014, Pages 800-803

  Uchiyama Tanaka, Yoko ^a  

^a Yoko Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ADULT; ARTICLE; ASTHMA; ATOPY; BIFIDOBACTERIUM; CHILD; CLINICAL ARTICLE; CONSTIPATION; DIET SUPPLEMENTATION; FATIGUE; FECES MICROFLORA; FEMALE; HUMAN; INDIGESTION; INGESTION; INTESTINE FLORA; LACTOBACILLUS BUCHNERI; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS FERMENTUM; LACTOBACILLUS HELVETICUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; MALE; NONHUMAN; POLLEN ALLERGY; RASH; ADOLESCENT; COHORT ANALYSIS; FECES; INTESTINE; LACTOBACILLUS; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; FECES; FEMALE; HUMANS; INTESTINES; LACTOBACILLUS; MALE; MICROBIOTA; MIDDLE AGED; PROBIOTICS; YOUNG ADULT;

EID: 84912082280     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2013.0245     Document Type: Article

References (15)

1. Hayashi H, Sakamoto M, Benno Y. Phylogenetic analysis of human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 2002;46:535-548.
2. Langendijk PS, Schut F, Jansen GJ, et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. With genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995;61:3069-3075.
3. Suau A, Bonnet R, Sutren M, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999;65:4799-4807.
4. Moor WE, Holdeman LV. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Environ Microbiol 1974;27:961-979.
5. Belkaid Y, Hand TW: Role of the microbiota in immunity and inflammation. Cell 2014;157:121-141.
6. Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut 2005;54:317-320.
7. Marik PE. Colonic flora, probiotics, obesity and diabetes. Front Endocrinol. 2012;3;87.
8. Hehemann J-H, Correc G, Barbeyron T, et al. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010;464:908-914.
9. Uchiyama-Tanaka Y. Colon irrigation and lymphocyte movement to peripheral blood. Biochem Res 2009;30:311-314.
10. Oshima N, Fujii T. Effect of administered lactobacillus isolated from FunaZushi on fecal micro flora of rats. J Food Microbiol 1994;11:129-132.
11. Ando A, Sakata S, Koizumi Y, et al. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm Bowel Dis 2007;13:955-962.
12. Nagashima K, Hisada T, Sato M, et al. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol 2002;69:1251-1262.
13. Nagashima K, Mochizuki J, Hisada T, et al. Phylogenetic analysis of 16S ribosomal RNA gene sequences from human fecal microbiota and improved utility of terminal restriction fragment length polymorphism profiling. Biosci Microflora 2006;25:99-107.
14. Nood E, Vrieze A, Niuwdrop M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013;368:407-415.
15. Hayashi H, Sakamoto M, Bennno Y. Fecal microbial diversity in a strict vegetarian as determined by molecular analysis and cultivation. Microbiol Immunol 2002;46:819-831.